Global Biologics and Biosimilars Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Biologics and Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics and Biosimilars.
The Biologics and Biosimilars market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologics and Biosimilars market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics and Biosimilars companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics and Biosimilars companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Biologics and Biosimilars market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologics and Biosimilars market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics and Biosimilars companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- Biogen
- Celltrion
- Sobi
- 3SBIO
- Changchun High Tech
- Kanghong Pharma
- Innovent Biologics
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
- Monoclonal Antibodies
- Interferon
- Insulin
- Vaccines
- Others
- Hospital
- Retail Pharmacy
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics and Biosimilars companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 LUXURY URNS MARKET OVERVIEW
1.1 Product Overview and Scope of Luxury Urns
1.2 Luxury Urns Segment by Type
1.2.1 Global Luxury Urns Market Value Comparison by Type (2023-2029)
1.2.2 Crystal
1.2.3 Gold
1.2.4 Silver
1.2.5 Wooden
1.2.6 Other
1.3 Luxury Urns Segment by Application
1.3.1 Global Luxury Urns Market Value by Application: (2023-2029)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Luxury Urns Market Size Estimates and Forecasts
1.4.1 Global Luxury Urns Revenue 2018-2029
1.4.2 Global Luxury Urns Sales 2018-2029
1.4.3 Global Luxury Urns Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 LUXURY URNS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Luxury Urns Sales Market Share by Manufacturers (2018-2023)
2.2 Global Luxury Urns Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Luxury Urns Average Price by Manufacturers (2018-2023)
2.4 Global Luxury Urns Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Luxury Urns, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Luxury Urns, Product Type & Application
2.7 Luxury Urns Market Competitive Situation and Trends
2.7.1 Luxury Urns Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Luxury Urns Players Market Share by Revenue
2.7.3 Global Luxury Urns Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 LUXURY URNS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Luxury Urns Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Luxury Urns Global Luxury Urns Sales by Region: 2018-2029
3.2.1 Global Luxury Urns Sales by Region: 2018-2023
3.2.2 Global Luxury Urns Sales by Region: 2024-2029
3.3 Global Luxury Urns Global Luxury Urns Revenue by Region: 2018-2029
3.3.1 Global Luxury Urns Revenue by Region: 2018-2023
3.3.2 Global Luxury Urns Revenue by Region: 2024-2029
3.4 North America Luxury Urns Market Facts & Figures by Country
3.4.1 North America Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Luxury Urns Sales by Country (2018-2029)
3.4.3 North America Luxury Urns Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Luxury Urns Market Facts & Figures by Country
3.5.1 Europe Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Luxury Urns Sales by Country (2018-2029)
3.5.3 Europe Luxury Urns Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Luxury Urns Market Facts & Figures by Country
3.6.1 Asia Pacific Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Luxury Urns Sales by Country (2018-2029)
3.6.3 Asia Pacific Luxury Urns Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Luxury Urns Market Facts & Figures by Country
3.7.1 Latin America Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Luxury Urns Sales by Country (2018-2029)
3.7.3 Latin America Luxury Urns Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Luxury Urns Market Facts & Figures by Country
3.8.1 Middle East and Africa Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Luxury Urns Sales by Country (2018-2029)
3.8.3 Middle East and Africa Luxury Urns Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Luxury Urns Sales by Type (2018-2029)
4.1.1 Global Luxury Urns Sales by Type (2018-2023)
4.1.2 Global Luxury Urns Sales by Type (2024-2029)
4.1.3 Global Luxury Urns Sales Market Share by Type (2018-2029)
4.2 Global Luxury Urns Revenue by Type (2018-2029)
4.2.1 Global Luxury Urns Revenue by Type (2018-2023)
4.2.2 Global Luxury Urns Revenue by Type (2024-2029)
4.2.3 Global Luxury Urns Revenue Market Share by Type (2018-2029)
4.3 Global Luxury Urns Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Luxury Urns Sales by Application (2018-2029)
5.1.1 Global Luxury Urns Sales by Application (2018-2023)
5.1.2 Global Luxury Urns Sales by Application (2024-2029)
5.1.3 Global Luxury Urns Sales Market Share by Application (2018-2029)
5.2 Global Luxury Urns Revenue by Application (2018-2029)
5.2.1 Global Luxury Urns Revenue by Application (2018-2023)
5.2.2 Global Luxury Urns Revenue by Application (2024-2029)
5.2.3 Global Luxury Urns Revenue Market Share by Application (2018-2029)
5.3 Global Luxury Urns Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Buebel Gruppe
6.1.1 Buebel Gruppe Corporation Information
6.1.2 Buebel Gruppe Description and Business Overview
6.1.3 Buebel Gruppe Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Buebel Gruppe Luxury Urns Product Portfolio
6.1.5 Buebel Gruppe Recent Developments/Updates
6.2 Ceabis
6.2.1 Ceabis Corporation Information
6.2.2 Ceabis Description and Business Overview
6.2.3 Ceabis Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ceabis Luxury Urns Product Portfolio
6.2.5 Ceabis Recent Developments/Updates
6.3 JC Walwyn & Sons Ltd
6.3.1 JC Walwyn & Sons Ltd Corporation Information
6.3.2 JC Walwyn & Sons Ltd Description and Business Overview
6.3.3 JC Walwyn & Sons Ltd Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.3.4 JC Walwyn & Sons Ltd Luxury Urns Product Portfolio
6.3.5 JC Walwyn & Sons Ltd Recent Developments/Updates
6.4 LAVABIS
6.4.1 LAVABIS Corporation Information
6.4.2 LAVABIS Description and Business Overview
6.4.3 LAVABIS Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LAVABIS Luxury Urns Product Portfolio
6.4.5 LAVABIS Recent Developments/Updates
6.5 Michael Aram
6.5.1 Michael Aram Corporation Information
6.5.2 Michael Aram Description and Business Overview
6.5.3 Michael Aram Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Michael Aram Luxury Urns Product Portfolio
6.5.5 Michael Aram Recent Developments/Updates
6.6 Modern Memorials
6.6.1 Modern Memorials Corporation Information
6.6.2 Modern Memorials Description and Business Overview
6.6.3 Modern Memorials Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Modern Memorials Luxury Urns Product Portfolio
6.6.5 Modern Memorials Recent Developments/Updates
6.7 Northwoods Casket Company
6.6.1 Northwoods Casket Company Corporation Information
6.6.2 Northwoods Casket Company Description and Business Overview
6.6.3 Northwoods Casket Company Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Northwoods Casket Company Luxury Urns Product Portfolio
6.7.5 Northwoods Casket Company Recent Developments/Updates
6.8 Perigold
6.8.1 Perigold Corporation Information
6.8.2 Perigold Description and Business Overview
6.8.3 Perigold Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Perigold Luxury Urns Product Portfolio
6.8.5 Perigold Recent Developments/Updates
6.9 Pieta Verr?
6.9.1 Pieta Verr? Corporation Information
6.9.2 Pieta Verr? Description and Business Overview
6.9.3 Pieta Verr? Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pieta Verr? Luxury Urns Product Portfolio
6.9.5 Pieta Verr? Recent Developments/Updates
6.10 URNS UK
6.10.1 URNS UK Corporation Information
6.10.2 URNS UK Description and Business Overview
6.10.3 URNS UK Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.10.4 URNS UK Luxury Urns Product Portfolio
6.10.5 URNS UK Recent Developments/Updates
6.11 ZRS International
6.11.1 ZRS International Corporation Information
6.11.2 ZRS International Luxury Urns Description and Business Overview
6.11.3 ZRS International Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ZRS International Luxury Urns Product Portfolio
6.11.5 ZRS International Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Luxury Urns Industry Chain Analysis
7.2 Luxury Urns Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Luxury Urns Production Mode & Process
7.4 Luxury Urns Sales and Marketing
7.4.1 Luxury Urns Sales Channels
7.4.2 Luxury Urns Distributors
7.5 Luxury Urns Customers
8 LUXURY URNS MARKET DYNAMICS
8.1 Luxury Urns Industry Trends
8.2 Luxury Urns Market Drivers
8.3 Luxury Urns Market Challenges
8.4 Luxury Urns Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Luxury Urns
1.2 Luxury Urns Segment by Type
1.2.1 Global Luxury Urns Market Value Comparison by Type (2023-2029)
1.2.2 Crystal
1.2.3 Gold
1.2.4 Silver
1.2.5 Wooden
1.2.6 Other
1.3 Luxury Urns Segment by Application
1.3.1 Global Luxury Urns Market Value by Application: (2023-2029)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Luxury Urns Market Size Estimates and Forecasts
1.4.1 Global Luxury Urns Revenue 2018-2029
1.4.2 Global Luxury Urns Sales 2018-2029
1.4.3 Global Luxury Urns Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 LUXURY URNS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Luxury Urns Sales Market Share by Manufacturers (2018-2023)
2.2 Global Luxury Urns Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Luxury Urns Average Price by Manufacturers (2018-2023)
2.4 Global Luxury Urns Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Luxury Urns, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Luxury Urns, Product Type & Application
2.7 Luxury Urns Market Competitive Situation and Trends
2.7.1 Luxury Urns Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Luxury Urns Players Market Share by Revenue
2.7.3 Global Luxury Urns Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 LUXURY URNS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Luxury Urns Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Luxury Urns Global Luxury Urns Sales by Region: 2018-2029
3.2.1 Global Luxury Urns Sales by Region: 2018-2023
3.2.2 Global Luxury Urns Sales by Region: 2024-2029
3.3 Global Luxury Urns Global Luxury Urns Revenue by Region: 2018-2029
3.3.1 Global Luxury Urns Revenue by Region: 2018-2023
3.3.2 Global Luxury Urns Revenue by Region: 2024-2029
3.4 North America Luxury Urns Market Facts & Figures by Country
3.4.1 North America Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Luxury Urns Sales by Country (2018-2029)
3.4.3 North America Luxury Urns Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Luxury Urns Market Facts & Figures by Country
3.5.1 Europe Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Luxury Urns Sales by Country (2018-2029)
3.5.3 Europe Luxury Urns Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Luxury Urns Market Facts & Figures by Country
3.6.1 Asia Pacific Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Luxury Urns Sales by Country (2018-2029)
3.6.3 Asia Pacific Luxury Urns Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Luxury Urns Market Facts & Figures by Country
3.7.1 Latin America Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Luxury Urns Sales by Country (2018-2029)
3.7.3 Latin America Luxury Urns Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Luxury Urns Market Facts & Figures by Country
3.8.1 Middle East and Africa Luxury Urns Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Luxury Urns Sales by Country (2018-2029)
3.8.3 Middle East and Africa Luxury Urns Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Luxury Urns Sales by Type (2018-2029)
4.1.1 Global Luxury Urns Sales by Type (2018-2023)
4.1.2 Global Luxury Urns Sales by Type (2024-2029)
4.1.3 Global Luxury Urns Sales Market Share by Type (2018-2029)
4.2 Global Luxury Urns Revenue by Type (2018-2029)
4.2.1 Global Luxury Urns Revenue by Type (2018-2023)
4.2.2 Global Luxury Urns Revenue by Type (2024-2029)
4.2.3 Global Luxury Urns Revenue Market Share by Type (2018-2029)
4.3 Global Luxury Urns Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Luxury Urns Sales by Application (2018-2029)
5.1.1 Global Luxury Urns Sales by Application (2018-2023)
5.1.2 Global Luxury Urns Sales by Application (2024-2029)
5.1.3 Global Luxury Urns Sales Market Share by Application (2018-2029)
5.2 Global Luxury Urns Revenue by Application (2018-2029)
5.2.1 Global Luxury Urns Revenue by Application (2018-2023)
5.2.2 Global Luxury Urns Revenue by Application (2024-2029)
5.2.3 Global Luxury Urns Revenue Market Share by Application (2018-2029)
5.3 Global Luxury Urns Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Buebel Gruppe
6.1.1 Buebel Gruppe Corporation Information
6.1.2 Buebel Gruppe Description and Business Overview
6.1.3 Buebel Gruppe Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Buebel Gruppe Luxury Urns Product Portfolio
6.1.5 Buebel Gruppe Recent Developments/Updates
6.2 Ceabis
6.2.1 Ceabis Corporation Information
6.2.2 Ceabis Description and Business Overview
6.2.3 Ceabis Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ceabis Luxury Urns Product Portfolio
6.2.5 Ceabis Recent Developments/Updates
6.3 JC Walwyn & Sons Ltd
6.3.1 JC Walwyn & Sons Ltd Corporation Information
6.3.2 JC Walwyn & Sons Ltd Description and Business Overview
6.3.3 JC Walwyn & Sons Ltd Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.3.4 JC Walwyn & Sons Ltd Luxury Urns Product Portfolio
6.3.5 JC Walwyn & Sons Ltd Recent Developments/Updates
6.4 LAVABIS
6.4.1 LAVABIS Corporation Information
6.4.2 LAVABIS Description and Business Overview
6.4.3 LAVABIS Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LAVABIS Luxury Urns Product Portfolio
6.4.5 LAVABIS Recent Developments/Updates
6.5 Michael Aram
6.5.1 Michael Aram Corporation Information
6.5.2 Michael Aram Description and Business Overview
6.5.3 Michael Aram Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Michael Aram Luxury Urns Product Portfolio
6.5.5 Michael Aram Recent Developments/Updates
6.6 Modern Memorials
6.6.1 Modern Memorials Corporation Information
6.6.2 Modern Memorials Description and Business Overview
6.6.3 Modern Memorials Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Modern Memorials Luxury Urns Product Portfolio
6.6.5 Modern Memorials Recent Developments/Updates
6.7 Northwoods Casket Company
6.6.1 Northwoods Casket Company Corporation Information
6.6.2 Northwoods Casket Company Description and Business Overview
6.6.3 Northwoods Casket Company Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Northwoods Casket Company Luxury Urns Product Portfolio
6.7.5 Northwoods Casket Company Recent Developments/Updates
6.8 Perigold
6.8.1 Perigold Corporation Information
6.8.2 Perigold Description and Business Overview
6.8.3 Perigold Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Perigold Luxury Urns Product Portfolio
6.8.5 Perigold Recent Developments/Updates
6.9 Pieta Verr?
6.9.1 Pieta Verr? Corporation Information
6.9.2 Pieta Verr? Description and Business Overview
6.9.3 Pieta Verr? Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pieta Verr? Luxury Urns Product Portfolio
6.9.5 Pieta Verr? Recent Developments/Updates
6.10 URNS UK
6.10.1 URNS UK Corporation Information
6.10.2 URNS UK Description and Business Overview
6.10.3 URNS UK Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.10.4 URNS UK Luxury Urns Product Portfolio
6.10.5 URNS UK Recent Developments/Updates
6.11 ZRS International
6.11.1 ZRS International Corporation Information
6.11.2 ZRS International Luxury Urns Description and Business Overview
6.11.3 ZRS International Luxury Urns Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ZRS International Luxury Urns Product Portfolio
6.11.5 ZRS International Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Luxury Urns Industry Chain Analysis
7.2 Luxury Urns Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Luxury Urns Production Mode & Process
7.4 Luxury Urns Sales and Marketing
7.4.1 Luxury Urns Sales Channels
7.4.2 Luxury Urns Distributors
7.5 Luxury Urns Customers
8 LUXURY URNS MARKET DYNAMICS
8.1 Luxury Urns Industry Trends
8.2 Luxury Urns Market Drivers
8.3 Luxury Urns Market Challenges
8.4 Luxury Urns Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Insulin
Table 5. Key Players of Vaccines
Table 6. Key Players of Others
Table 7. Global Biologics and Biosimilars Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Biologics and Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Biologics and Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Biologics and Biosimilars Market Share by Region (2018-2023)
Table 11. Global Biologics and Biosimilars Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Biologics and Biosimilars Market Share by Region (2024-2029)
Table 13. Biologics and Biosimilars Market Trends
Table 14. Biologics and Biosimilars Market Drivers
Table 15. Biologics and Biosimilars Market Challenges
Table 16. Biologics and Biosimilars Market Restraints
Table 17. Global Biologics and Biosimilars Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Biologics and Biosimilars Market Share by Players (2018-2023)
Table 19. Global Top Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2022)
Table 20. Ranking of Global Top Biologics and Biosimilars Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Biologics and Biosimilars Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biologics and Biosimilars Product Solution and Service
Table 24. Date of Enter into Biologics and Biosimilars Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biologics and Biosimilars Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Biologics and Biosimilars Revenue Market Share by Type (2018-2023)
Table 28. Global Biologics and Biosimilars Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Biologics and Biosimilars Revenue Market Share by Type (2024-2029)
Table 30. Global Biologics and Biosimilars Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Biologics and Biosimilars Revenue Market Share by Application (2018-2023)
Table 32. Global Biologics and Biosimilars Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Biologics and Biosimilars Revenue Market Share by Application (2024-2029)
Table 34. North America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Biologics and Biosimilars Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Biologics and Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Biologics and Biosimilars Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Biologics and Biosimilars Product
Table 52. Roche Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Amgen Company Detail
Table 55. Amgen Business Overview
Table 56. Amgen Biologics and Biosimilars Product
Table 57. Amgen Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 58. Amgen Recent Development
Table 59. AbbVie Company Detail
Table 60. AbbVie Business Overview
Table 61. AbbVie Biologics and Biosimilars Product
Table 62. AbbVie Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Biologics and Biosimilars Product
Table 67. Sanofi Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Biologics and Biosimilars Product
Table 72. Johnson & Johnson Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Pfizer Company Detail
Table 75. Pfizer Business Overview
Table 76. Pfizer Biologics and Biosimilars Product
Table 77. Pfizer Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Novo Nordisk Company Detail
Table 80. Novo Nordisk Business Overview
Table 81. Novo Nordisk Biologics and Biosimilars Product
Table 82. Novo Nordisk Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 83. Novo Nordisk Recent Development
Table 84. Eli Lilly Company Detail
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Biologics and Biosimilars Product
Table 87. Eli Lilly Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 88. Eli Lilly Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Biologics and Biosimilars Product
Table 92. Novartis Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Merck Company Detail
Table 95. Merck Business Overview
Table 96. Merck Biologics and Biosimilars Product
Table 97. Merck Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Biogen Company Detail
Table 100. Biogen Business Overview
Table 101. Biogen Biologics and Biosimilars Product
Table 102. Biogen Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 103. Biogen Recent Development
Table 104. Celltrion Company Detail
Table 105. Celltrion Business Overview
Table 106. Celltrion Biologics and Biosimilars Product
Table 107. Celltrion Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 108. Celltrion Recent Development
Table 109. Sobi Company Detail
Table 110. Sobi Business Overview
Table 111. Sobi Biologics and Biosimilars Product
Table 112. Sobi Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 113. Sobi Recent Development
Table 114. 3SBIO Company Detail
Table 115. 3SBIO Business Overview
Table 116. 3SBIO Biologics and Biosimilars Product
Table 117. 3SBIO Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 118. 3SBIO Recent Development
Table 119. Changchun High Tech Company Detail
Table 120. Changchun High Tech Business Overview
Table 121. Changchun High Tech Biologics and Biosimilars Product
Table 122. Changchun High Tech Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 123. Changchun High Tech Recent Development
Table 124. Kanghong Pharma Company Detail
Table 125. Kanghong Pharma Business Overview
Table 126. Kanghong Pharma Biologics and Biosimilars Product
Table 127. Kanghong Pharma Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 128. Kanghong Pharma Recent Development
Table 129. Innovent Biologics Company Detail
Table 130. Innovent Biologics Business Overview
Table 131. Innovent Biologics Biologics and Biosimilars Product
Table 132. Innovent Biologics Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 133. Innovent Biologics Recent Development
Table 134. Gan&Lee Company Detail
Table 135. Gan&Lee Business Overview
Table 136. Gan&Lee Biologics and Biosimilars Product
Table 137. Gan&Lee Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 138. Gan&Lee Recent Development
Table 139. Tonghua Dongbao Company Detail
Table 140. Tonghua Dongbao Business Overview
Table 141. Tonghua Dongbao Biologics and Biosimilars Product
Table 142. Tonghua Dongbao Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 143. Tonghua Dongbao Recent Development
Table 144. United Laboratory Company Detail
Table 145. United Laboratory Business Overview
Table 146. United Laboratory Biologics and Biosimilars Product
Table 147. United Laboratory Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 148. United Laboratory Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Insulin
Table 5. Key Players of Vaccines
Table 6. Key Players of Others
Table 7. Global Biologics and Biosimilars Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Biologics and Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Biologics and Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Biologics and Biosimilars Market Share by Region (2018-2023)
Table 11. Global Biologics and Biosimilars Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Biologics and Biosimilars Market Share by Region (2024-2029)
Table 13. Biologics and Biosimilars Market Trends
Table 14. Biologics and Biosimilars Market Drivers
Table 15. Biologics and Biosimilars Market Challenges
Table 16. Biologics and Biosimilars Market Restraints
Table 17. Global Biologics and Biosimilars Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Biologics and Biosimilars Market Share by Players (2018-2023)
Table 19. Global Top Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2022)
Table 20. Ranking of Global Top Biologics and Biosimilars Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Biologics and Biosimilars Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biologics and Biosimilars Product Solution and Service
Table 24. Date of Enter into Biologics and Biosimilars Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biologics and Biosimilars Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Biologics and Biosimilars Revenue Market Share by Type (2018-2023)
Table 28. Global Biologics and Biosimilars Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Biologics and Biosimilars Revenue Market Share by Type (2024-2029)
Table 30. Global Biologics and Biosimilars Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Biologics and Biosimilars Revenue Market Share by Application (2018-2023)
Table 32. Global Biologics and Biosimilars Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Biologics and Biosimilars Revenue Market Share by Application (2024-2029)
Table 34. North America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Biologics and Biosimilars Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Biologics and Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Biologics and Biosimilars Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Biologics and Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Biologics and Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Biologics and Biosimilars Product
Table 52. Roche Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Amgen Company Detail
Table 55. Amgen Business Overview
Table 56. Amgen Biologics and Biosimilars Product
Table 57. Amgen Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 58. Amgen Recent Development
Table 59. AbbVie Company Detail
Table 60. AbbVie Business Overview
Table 61. AbbVie Biologics and Biosimilars Product
Table 62. AbbVie Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Biologics and Biosimilars Product
Table 67. Sanofi Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Biologics and Biosimilars Product
Table 72. Johnson & Johnson Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Pfizer Company Detail
Table 75. Pfizer Business Overview
Table 76. Pfizer Biologics and Biosimilars Product
Table 77. Pfizer Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Novo Nordisk Company Detail
Table 80. Novo Nordisk Business Overview
Table 81. Novo Nordisk Biologics and Biosimilars Product
Table 82. Novo Nordisk Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 83. Novo Nordisk Recent Development
Table 84. Eli Lilly Company Detail
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Biologics and Biosimilars Product
Table 87. Eli Lilly Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 88. Eli Lilly Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Biologics and Biosimilars Product
Table 92. Novartis Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Merck Company Detail
Table 95. Merck Business Overview
Table 96. Merck Biologics and Biosimilars Product
Table 97. Merck Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Biogen Company Detail
Table 100. Biogen Business Overview
Table 101. Biogen Biologics and Biosimilars Product
Table 102. Biogen Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 103. Biogen Recent Development
Table 104. Celltrion Company Detail
Table 105. Celltrion Business Overview
Table 106. Celltrion Biologics and Biosimilars Product
Table 107. Celltrion Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 108. Celltrion Recent Development
Table 109. Sobi Company Detail
Table 110. Sobi Business Overview
Table 111. Sobi Biologics and Biosimilars Product
Table 112. Sobi Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 113. Sobi Recent Development
Table 114. 3SBIO Company Detail
Table 115. 3SBIO Business Overview
Table 116. 3SBIO Biologics and Biosimilars Product
Table 117. 3SBIO Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 118. 3SBIO Recent Development
Table 119. Changchun High Tech Company Detail
Table 120. Changchun High Tech Business Overview
Table 121. Changchun High Tech Biologics and Biosimilars Product
Table 122. Changchun High Tech Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 123. Changchun High Tech Recent Development
Table 124. Kanghong Pharma Company Detail
Table 125. Kanghong Pharma Business Overview
Table 126. Kanghong Pharma Biologics and Biosimilars Product
Table 127. Kanghong Pharma Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 128. Kanghong Pharma Recent Development
Table 129. Innovent Biologics Company Detail
Table 130. Innovent Biologics Business Overview
Table 131. Innovent Biologics Biologics and Biosimilars Product
Table 132. Innovent Biologics Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 133. Innovent Biologics Recent Development
Table 134. Gan&Lee Company Detail
Table 135. Gan&Lee Business Overview
Table 136. Gan&Lee Biologics and Biosimilars Product
Table 137. Gan&Lee Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 138. Gan&Lee Recent Development
Table 139. Tonghua Dongbao Company Detail
Table 140. Tonghua Dongbao Business Overview
Table 141. Tonghua Dongbao Biologics and Biosimilars Product
Table 142. Tonghua Dongbao Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 143. Tonghua Dongbao Recent Development
Table 144. United Laboratory Company Detail
Table 145. United Laboratory Business Overview
Table 146. United Laboratory Biologics and Biosimilars Product
Table 147. United Laboratory Revenue in Biologics and Biosimilars Business (2018-2023) & (US$ Million)
Table 148. United Laboratory Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Biologics and Biosimilars Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Biologics and Biosimilars Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Interferon Features
Figure 5. Insulin Features
Figure 6. Vaccines Features
Figure 7. Others Features
Figure 8. Global Biologics and Biosimilars Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Biologics and Biosimilars Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Biologics and Biosimilars Report Years Considered
Figure 14. Global Biologics and Biosimilars Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Biologics and Biosimilars Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Biologics and Biosimilars Market Share by Region: 2022 VS 2029
Figure 17. Global Biologics and Biosimilars Market Share by Players in 2022
Figure 18. Global Top Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2022
Figure 20. North America Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 22. United States Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 26. Germany Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Biologics and Biosimilars Market Share by Region (2018-2029)
Figure 34. China Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 42. Mexico Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 46. Turkey Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 49. Amgen Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 50. AbbVie Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 54. Novo Nordisk Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 58. Biogen Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 59. Celltrion Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 60. Sobi Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 61. 3SBIO Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 62. Changchun High Tech Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 63. Kanghong Pharma Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 64. Innovent Biologics Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 65. Gan&Lee Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 66. Tonghua Dongbao Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 67. United Laboratory Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Figure 1. Global Biologics and Biosimilars Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Biologics and Biosimilars Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Interferon Features
Figure 5. Insulin Features
Figure 6. Vaccines Features
Figure 7. Others Features
Figure 8. Global Biologics and Biosimilars Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Biologics and Biosimilars Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Biologics and Biosimilars Report Years Considered
Figure 14. Global Biologics and Biosimilars Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Biologics and Biosimilars Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Biologics and Biosimilars Market Share by Region: 2022 VS 2029
Figure 17. Global Biologics and Biosimilars Market Share by Players in 2022
Figure 18. Global Top Biologics and Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2022
Figure 20. North America Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 22. United States Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 26. Germany Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Biologics and Biosimilars Market Share by Region (2018-2029)
Figure 34. China Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 42. Mexico Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Biologics and Biosimilars Market Share by Country (2018-2029)
Figure 46. Turkey Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Biologics and Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 49. Amgen Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 50. AbbVie Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 54. Novo Nordisk Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 58. Biogen Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 59. Celltrion Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 60. Sobi Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 61. 3SBIO Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 62. Changchun High Tech Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 63. Kanghong Pharma Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 64. Innovent Biologics Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 65. Gan&Lee Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 66. Tonghua Dongbao Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 67. United Laboratory Revenue Growth Rate in Biologics and Biosimilars Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
